Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Janssen-Cilag International NV - Exploring questions in metastatic prostate cancer

Question 2: What is the role of chemotherapy alongside hormonal treatments in mHSPC?

Date

10 Sep 2022

Session

Janssen-Cilag International NV - Exploring questions in metastatic prostate cancer

Topics

Tumour Site

Prostate Cancer

Presenters

Laura-Maria Krabbe

Authors

G. Attard1, L. Krabbe2

Author affiliations

  • 1 Research Department Of Oncology, UCL Cancer Institute - UCL - London's Global University, WC1 E6BT - London/GB
  • 2 Urology Department, UKM - University Hospital Muenster, 48149 - Muenster/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Laura-Maria Krabbe

Session: Janssen-Cilag International NV - Exploring questions in metastatic prostate cancer

Resources:

Webcast

Close

Presenter: Gerhardt Attard

Session: Janssen-Cilag International NV - Exploring questions in metastatic prostate cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.